Laura Kalmbach

Papers

Total Citations

H-Index

About

Laura Kalmbach is a rising figure in prostate cancer imaging, whose work centers on advancing quantitative MRI techniques to improve diagnostic precision. Her most impactful contribution, the 2022 study "T2 mapping for the characterization of prostate lesions," has already garnered 22 citations, underscoring its significance in the field. In this seminal work, Kalmbach and her team tackled a critical clinical challenge: differentiating prostate cancer (PCa) from benign mimics like chronic prostatitis, which often present as non-specific inflammatory infiltrates and atrophy on standard imaging. By evaluating the diagnostic accuracy of quantitative T2 and ADC values, she demonstrated how these metrics can reliably distinguish malignant from benign lesions, reducing unnecessary biopsies and overtreatment. This research bridges a key gap in radiology, offering a non-invasive, objective tool for lesion characterization. Kalmbach’s work is particularly notable for its focus on clinically relevant differential diagnoses, directly impacting patient management. As her citation count grows, she is establishing herself as a leader in quantitative prostate MRI, with potential to shape future guidelines for prostate cancer diagnosis.